185 related articles for article (PubMed ID: 31919239)
1. Hormonal contraception and HIV acquisition among women: an updated systematic review.
Curtis KM; Hannaford PC; Rodriguez MI; Chipato T; Steyn PS; Kiarie JN
BMJ Sex Reprod Health; 2020 Jan; 46(1):8-16. PubMed ID: 31919239
[TBL] [Abstract][Full Text] [Related]
2. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
Singata-Madliki M; Lawrie TA; Balakrishna Y; d'Hellencourt FC; Hofmeyr GJ
Reprod Health; 2021 Sep; 18(1):192. PubMed ID: 34587971
[TBL] [Abstract][Full Text] [Related]
4. Copper intrauterine device use and HIV acquisition in women: a systematic review.
Hannaford PC; Ti A; Chipato T; Curtis KM
BMJ Sex Reprod Health; 2020 Jan; 46(1):17-25. PubMed ID: 31919240
[TBL] [Abstract][Full Text] [Related]
5. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K;
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723
[TBL] [Abstract][Full Text] [Related]
6. Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial.
Hofmeyr GJ; Singata-Madliki M; Batting J; Steyn P; Thomas KK; Issema R; Beesham I; Mbatsane E; Morrison C; Deese J; Smit J; Philip N; Palanee-Phillips T; Reddy K; Onono M; Mastro TD; Baeten JM;
PLoS One; 2024; 19(5):e0299802. PubMed ID: 38722832
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
Mugo NR; Stalter RM; Heffron R; Rees H; Scoville CW; Morrison C; Kourtis AP; Bukusi E; Beksinka M; Philip NM; Beesham I; Deese J; Edward V; Donnell D; Baeten JM;
Clin Infect Dis; 2022 Sep; 75(4):586-595. PubMed ID: 34910143
[TBL] [Abstract][Full Text] [Related]
8. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.
Polis CB; Curtis KM; Hannaford PC; Phillips SJ; Chipato T; Kiarie JN; Westreich DJ; Steyn PS
AIDS; 2016 Nov; 30(17):2665-2683. PubMed ID: 27500670
[TBL] [Abstract][Full Text] [Related]
9. Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial.
Beksinska M; Issema R; Beesham I; Lalbahadur T; Thomas K; Morrison C; Hofmeyr GJ; Steyn PS; Mugo N; Palanee-Phillips T; Ahmed K; Nair G; Baeten JM; Smit J
EClinicalMedicine; 2021 Apr; 34():100800. PubMed ID: 33898953
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K
Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180
[TBL] [Abstract][Full Text] [Related]
11. Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial.
Ryan R; Mussa A; Singtaa-Madliki M; Batting J; Balakrishna Y; Morroni C; Hofmeyr GJ
Front Glob Womens Health; 2022; 3():887541. PubMed ID: 35669313
[TBL] [Abstract][Full Text] [Related]
12. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception.
Onono M; Nanda K; Heller KB; Taylor D; Yacobson I; Heffron R; Kasaro MP; Louw CE; Nhlabasti Z; Palanee-Phillips T; Smit J; Wakhungu I; Gichangi PB; Mugo NR; Morrison C; Baeten JM;
Contracept X; 2020; 2():100026. PubMed ID: 32577615
[TBL] [Abstract][Full Text] [Related]
14. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.
Hapgood JP
AIDS Res Hum Retroviruses; 2020 May; 36(5):357-366. PubMed ID: 31797677
[TBL] [Abstract][Full Text] [Related]
15. Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
Palanee-Phillips T; Brown ER; Szydlo D; Matovu Kiweewa F; Pather A; Harkoo I; Nair G; Soto-Torres L; Hillier SL; Baeten JM;
AIDS; 2019 Aug; 33(10):1619-1622. PubMed ID: 31306167
[TBL] [Abstract][Full Text] [Related]
16. Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial.
Deese J; Chen PL; Gao X; Heffron R; Hobbs M; Lapple D; Jaspan H; Miller A; Nair G; Onono M; Palanee-Phillips T; Reddy K; Steiner MJ
AIDS Behav; 2023 Mar; 27(3):978-983. PubMed ID: 36357806
[TBL] [Abstract][Full Text] [Related]
17. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Bunjun R; Ramla TF; Jaumdally SZ; Noël-Romas L; Ayele H; Brown BP; Gamieldien H; Harryparsad R; Dabee S; Nair G; Onono M; Palanee-Phillips T; Scoville CW; Heller KB; Baeten JM; Bosinger SE; Burgener A; Passmore JS; Jaspan H; Heffron R
Clin Infect Dis; 2022 Nov; 75(11):2000-2011. PubMed ID: 35941737
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.
Tanko RF; Bunjun R; Dabee S; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Harryparsad R; Happel AU; Gamieldien H; Qumbelo Y; Sinkala M; Scoville CW; Heller K; Baeten JM; Bosinger SE; Burgener A; Heffron R; Jaspan HB; Passmore JAS
J Infect Dis; 2022 Sep; 226(5):907-919. PubMed ID: 35263421
[TBL] [Abstract][Full Text] [Related]
19. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
Deese J; Philip N; Lind M; Ahmed K; Batting J; Beksinska M; Edward VA; Louw CE; Onono M; Palanee-Phillips T; Smit JA; Baeten JM; Donnell D; Mastro TD; Mugo NR; Nanda K; Rees H; Morrison C
Sex Transm Infect; 2021 Jun; 97(4):249-255. PubMed ID: 33208512
[TBL] [Abstract][Full Text] [Related]
20. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
